Log in
RegisterSUPAC level 3 changes for MR formulations [Regulatives / Guidelines]
Dear All,
My questions are on SUPAC IR and MR guidance about the conduction of BE study due to change in manufacturing site change:
1. IR product if we change the manufacturing site, do we need to perform BE study as suggested in SUPAC guidance for IR? or it would be okay to justify based on in vitro data?
2. For MR product SUPAC MR guidance is not clear for any requirement of conducting BE study. where as we do perform Fasting for such changes in manufacturing site change. are we doing correct?
regards,
Mithu.
My questions are on SUPAC IR and MR guidance about the conduction of BE study due to change in manufacturing site change:
1. IR product if we change the manufacturing site, do we need to perform BE study as suggested in SUPAC guidance for IR? or it would be okay to justify based on in vitro data?
2. For MR product SUPAC MR guidance is not clear for any requirement of conducting BE study. where as we do perform Fasting for such changes in manufacturing site change. are we doing correct?
regards,
Mithu.
Complete thread:
- SUPAC level 3 changes for MR formulationsMithu 2019-09-30 07:42
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- SUPAC level 3 changes for MR formulations jag009 2019-10-22 21:31
- SUPAC level 3 changes for MR formulations Mithu 2019-10-23 09:21
- SUPAC level 3 changes for MR formulations jag009 2019-10-24 05:34
- SUPAC level 3 changes for MR formulations Mithu 2019-10-23 09:21
- SUPAC level 3 changes for MR formulations jag009 2019-10-22 21:31
Ing. Helmut Schütz